NCT02271126 - TEG Anticoagulation Monitoring During ECMO | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 2, 2014

Primary Completion Date

September 30, 2016

Study Completion Date

November 30, 2016

Conditions

Extracorporeal Membrane Oxygenation Complication

Interventions

DEVICE

TEG monitoring

anticoagulation monitoring during ECMO will be according to TEG

DEVICE

APTT monitoring

anticoagulation monitoring during ECMO will be according to aPTT

DRUG

Heparin

Anticoagulation provided to patients in ECMO

Trial Locations (1)

Fondazione IRCCS Cà Granda - Ospedale Maggiore Policlinico, Milan

All Listed Sponsors

collaborator

The Mediterranean Institute for Transplantation and Advanced Specialized Therapies

OTHER

lead

Policlinico Hospital

OTHER